Nissen Inc.
Nissen Inc. (6543.T) Financial Performance & Income Statement Overview
Review Nissen Inc. (6543.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Nissen Inc. (6543.T) Income Statement & Financial Overview
Review Nissen Inc. 6543.T income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.48B | $1.42B | $1.18B | $1.46B |
| Cost of Revenue | $1.11B | $1.02B | $908.13M | $1.10B |
| Gross Profit | $370.47M | $393.00M | $267.13M | $364.89M |
| Gross Profit Ratio | $0.25 | $0.28 | $0.23 | $0.25 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $287.18M | $237.00M | $230.61M | $247.34M |
| Operating Expenses | $287.18M | $237.00M | $230.61M | $247.34M |
| Total Costs & Expenses | $1.40B | $1.26B | $1.14B | $1.35B |
| Interest Income | $392000.00 | $0.00 | $60000.00 | $8000.00 |
| Interest Expense | $915000.00 | $0.00 | $855000.00 | $871000.00 |
| Depreciation & Amortization | $34.19M | $29.75M | $1.99M | $29.001M |
| EBITDA | $119.12M | $185.75M | $38.51M | $120.65M |
| EBITDA Ratio | $0.08 | $0.13 | $0.03 | $0.08 |
| Operating Income | $83.29M | $156.00M | $36.52M | $117.55M |
| Operating Income Ratio | $0.06 | $0.11 | $0.03 | $0.08 |
| Other Income/Expenses (Net) | $723000.00 | $14.00M | -$27.90M | $2.23M |
| Income Before Tax | $84.02M | $170.00M | $8.62M | $119.78M |
| Income Before Tax Ratio | $0.06 | $0.12 | $0.007 | $0.08 |
| Income Tax Expense | $28.34M | $55.00M | $13.12M | $38.05M |
| Net Income | $55.67M | $115.00M | -$4.50M | $81.73M |
| Net Income Ratio | $0.04 | $0.08 | -$0.004 | $0.06 |
| EPS | $14.59 | $30.09 | -$1.31 | $21.57 |
| Diluted EPS | $14.59 | $30.15 | -$1.18 | $21.35 |
| Weighted Avg Shares Outstanding | $3.82M | $3.82M | $3.43M | $3.79M |
| Weighted Avg Shares Outstanding (Diluted) | $3.82M | $3.81M | $3.81M | $3.83M |
Over the past four quarters, Nissen Inc. demonstrated steady revenue growth, increasing from $1.46B in Q1 2024 to $1.48B in Q4 2024. Operating income reached $83.29M in Q4 2024, maintaining a consistent 6% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $119.12M, reflecting operational efficiency. Net income dropped to $55.67M, with EPS at $14.59. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan